6533b82cfe1ef96bd12901c9
RESEARCH PRODUCT
Need for liver evaluation in polycystic ovary syndrome
Enrico Carminasubject
Nonalcoholic steatohepatitisMetabolic Syndromemedicine.medical_specialtySettore MED/12 - GastroenterologiaSettore MED/09 - Medicina InternaHepatologyPCOS Liver function NASH NAFLDbusiness.industrynutritional and metabolic diseasesmedicine.diseaseGastroenterologyPolycystic ovarySettore MED/13 - EndocrinologiaFatty LiverLiver Function TestsInternal medicineNonalcoholic fatty liver diseasePrevalenceMedicineHumansFemalebusinessPolycystic Ovary Syndromedescription
Medicine is changing and requires a more in-depth knowledge also in fields that were previously considered completely different and dedicated to other specialists. A good example of this general trend is the paper by Cerda et al. [1] that shows a high prevalence of nonalcoholic fatty liver disease (NAFLD) in women with Polycystic Ovary Syndrome (PCOS). The authors studied 41 young women with PCOS and found that 17 patients (41%) had NAFLD. In addition, 7 patients with NAFLD had increased aminotransferase levels raising the possibility of a transition to nonalcoholic steatohepatitis (NASH). Other reports have shown similar data recently [2–5]. It is time therefore that doctors caring for patients with liver diseases start to collaborate with the specialists (gynecologists, endocrinologists), who generally treat patients with PCOS and vice versa.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2007-07-13 |